Advertisement

IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies

Elisa Bergaggio, Chiara Riganti, Giulia Garaffo, Nicoletta Vitale, Elisabetta Mereu, Cecilia Bandini, Elisa Pellegrino, Verdiana Pullano, Paola Omedè, Katia Todoerti, Luciano Cascione, Valentina Audrito, Anna Riccio, Antonio Rossi, Francesco Bertoni, Silvia Deaglio, Antonino Neri, Antonio Palumbo and Roberto Piva

Article Information

Citation 
vol. 133 no. 2 156-167
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 16, 2018
  • Accepted November 16, 2018
  • Published online January 10, 2019.

Article Versions


Contributors 
  • Elisa Bergaggio, 1Department of Molecular Biotechnology and Health Sciences and
  • Chiara Riganti, 2Department of Oncology, University of Torino, Torino, Italy;
  • Giulia Garaffo, 1Department of Molecular Biotechnology and Health Sciences and
  • Nicoletta Vitale, 1Department of Molecular Biotechnology and Health Sciences and
  • Elisabetta Mereu, 1Department of Molecular Biotechnology and Health Sciences and
  • Cecilia Bandini, 3Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy; 4Hematology Unit, Fondazione Cà Granda Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Maggiore Policlinico, Milano, Italy;
  • Elisa Pellegrino, 1Department of Molecular Biotechnology and Health Sciences and
  • Verdiana Pullano, 1Department of Molecular Biotechnology and Health Sciences and
  • Paola Omedè, 5Città Della Salute e della Scienza Hospital, Torino, Italy;
  • Katia Todoerti, 3Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy; 4Hematology Unit, Fondazione Cà Granda Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Maggiore Policlinico, Milano, Italy;
  • Luciano Cascione, 6Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland;
  • Valentina Audrito, 7Department of Medical Sciences, University of Torino, Torino, Italy; 8Italian Institute for Genomic Medicine, Torino, Italy;
  • Anna Riccio, 9Department of Biology, University of Rome Tor Vergata, Roma, Italy; and
  • Antonio Rossi, 10Institute of Translational Pharmacology, Consiglio Nazionale delle Ricerche, Roma, Italy
  • Francesco Bertoni, 6Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland;
  • Silvia Deaglio, 7Department of Medical Sciences, University of Torino, Torino, Italy; 8Italian Institute for Genomic Medicine, Torino, Italy;
  • Antonino Neri, 3Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy; 4Hematology Unit, Fondazione Cà Granda Istituto di Ricovero e Cura a Carattere Scientifico, Ospedale Maggiore Policlinico, Milano, Italy;
  • Antonio Palumbo, 1Department of Molecular Biotechnology and Health Sciences and
  • Roberto Piva, 1Department of Molecular Biotechnology and Health Sciences and

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output